DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 10 of 22 descriptions
Filter by
Reset
No.
薬物名(臨床試験情報から抽出)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
指定難病告示番号
1
EU-approved
RoActemra
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
2
RoActemra
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
11件:
40
40
,
41
,
44
,
46
,
50
,
51
,
86
,
107
,
266
,
271
,
331
3
RoActemra
(R)
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
4
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE
ROACTEMRA
- 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4
...
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
2件:
46
46
,
51
5
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO
ROACTEMRA
- 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4M
...
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
6
RoActemra
162 mg
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
2件:
46
46
,
51
7
RoActemra
162 mg solution for injection in pre-filled syringe
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
41
41
8
RoActemra
162 mg solution injectable en seringue préremplie
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46
9
RoActemra
162 mg soluzione iniettabile in siringa preriempita
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
50
50
10
RoActemra
20 mg/ml concentrado para solución para perfusión
1件:
Tocilizumab
Tocilizumab
(Synonym:
Roactemra
)
1件:
D02596
D02596
1件:
IL6R
IL6R
💬
12件:
Coronavirus disease - COVID-19
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase inhibitor resistance
,
HIF-1 signaling pathway
,
Hematopoietic cell lineage
,
Human cytomegalovirus infection
,
JAK-STAT signaling pathway
,
Non-alcoholic fatty liver disease
,
PI3K-Akt signaling pathway
,
Pathways in cancer
,
Th17 cell differentiation
,
Viral protein interaction with cytokine and cytokine receptor
💬
12件:
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
EGFR tyrosine kinase in
...
1件:
46
46